Q1061X mutation with and without left ventricular hypertrophy (LVH) and non-affected relatives, and the association of the metabolome to the echocardiographic parameters.Q1061X mutation.Our study implicates the potential role of branched chain amino acids, triglycerides and ether phospholipids in HCM, as well as suggests an association of these metabolites with remodeling and dysfunction of the left ventricle
Cardiomyopathies are defined as diseases of the myocardium associated with cardiac dysfunction and a...
Molecular genetic research in hypertrophic cardiomyopathy (HCM) has shown that this heart muscle dis...
Familial hypertrophic cardiomyopathy (FHC) is associated with mild to severe cardiac problems and is...
Q1061X mutation with and without left ventricular hypertrophy (LVH) and non-affected relatives, and ...
Aims Mutations in the cardiac myosin-binding protein C gene (MYBPC3) are the most common genetic cau...
<div><p>Aims</p><p>Mutations in the cardiac myosin-binding protein C gene (<i>MYBPC3</i>) are the mo...
Aims Mutations in the cardiac myosin-binding protein C gene (MYBPC3) are the most common genetic cau...
Hypertrophic (HCM) and dilated (DCM) cardiomyopathies are among the leading causes of sudden cardiac...
The purpose of this study was to assess whether metabolomics, associated with echocardiography, was ...
Despite the clinical importance of hypertrophic cardiomyopathy (HCM) and a recognition that aberrant...
Hypertrophic cardiomyopathy (HCM) has been informative as a genetic model of cardiac hypertrophy. Un...
Hypertrophic Cardiomyopathy (HCM) is a common inherited heart disease with poor risk prediction due ...
Hypertrophic cardiomyopathy (HCM) is a genetic disorder characterized by left ventricular hypertroph...
Hypertrophic Cardiomyopathy (HCM) is a common inherited heart disease with poor risk prediction due ...
BackgroundHypertrophic cardiomyopathy (HCM) is a complex disease partly explained by the effects of ...
Cardiomyopathies are defined as diseases of the myocardium associated with cardiac dysfunction and a...
Molecular genetic research in hypertrophic cardiomyopathy (HCM) has shown that this heart muscle dis...
Familial hypertrophic cardiomyopathy (FHC) is associated with mild to severe cardiac problems and is...
Q1061X mutation with and without left ventricular hypertrophy (LVH) and non-affected relatives, and ...
Aims Mutations in the cardiac myosin-binding protein C gene (MYBPC3) are the most common genetic cau...
<div><p>Aims</p><p>Mutations in the cardiac myosin-binding protein C gene (<i>MYBPC3</i>) are the mo...
Aims Mutations in the cardiac myosin-binding protein C gene (MYBPC3) are the most common genetic cau...
Hypertrophic (HCM) and dilated (DCM) cardiomyopathies are among the leading causes of sudden cardiac...
The purpose of this study was to assess whether metabolomics, associated with echocardiography, was ...
Despite the clinical importance of hypertrophic cardiomyopathy (HCM) and a recognition that aberrant...
Hypertrophic cardiomyopathy (HCM) has been informative as a genetic model of cardiac hypertrophy. Un...
Hypertrophic Cardiomyopathy (HCM) is a common inherited heart disease with poor risk prediction due ...
Hypertrophic cardiomyopathy (HCM) is a genetic disorder characterized by left ventricular hypertroph...
Hypertrophic Cardiomyopathy (HCM) is a common inherited heart disease with poor risk prediction due ...
BackgroundHypertrophic cardiomyopathy (HCM) is a complex disease partly explained by the effects of ...
Cardiomyopathies are defined as diseases of the myocardium associated with cardiac dysfunction and a...
Molecular genetic research in hypertrophic cardiomyopathy (HCM) has shown that this heart muscle dis...
Familial hypertrophic cardiomyopathy (FHC) is associated with mild to severe cardiac problems and is...